Texas Instruments Outlook - A Deep Divergence Between Fundamentals and Technicals
Market Snapshot
Takeaway: Despite strong fundamentals, Texas InstrumentsTXN-- (TXN) faces bearish technical signals, with the stock down 10.82% recently.
News Highlights
- McKinsey's Tariff Analysis – A recent report by McKinsey on U.S. tariffs highlights potential risks for the semiconductor sector, raising questions about how global policy could affect TXN’s supply chain.
- SOXX ETF Outflow – The US Semiconductors ETF (SOXX) saw a $750M outflow in May 2025, signaling reduced institutional interest in the sector, which could indirectly pressure TXN’s stock.
- Japan-U.S. Cooperation – Japan announced plans to propose stronger cooperation with the U.S. on rare earths and semiconductors, potentially reshaping the industry landscape, with TXNTXN-- likely to benefit from long-term trade stability.
Analyst Views & Fundamentals
Analyst ratings for TXN show a mixed outlook. The simple average rating is 3.33, while the performance-weighted rating is 2.10, indicating that recent recommendations have leaned bearish or neutral.
- Analyst Consensus – Three analysts from three institutions issued ratings in the last 20 days: one 'Strong Buy', one 'Neutral', and one 'Sell'. This lack of consensus suggests uncertainty in the market.
- Rating vs. Price Trend – The recent price drop (-10.82%) aligns with the bearish weighted rating. Analysts with better historical performance, like Cody Acree (Benchmark), are bullish, but recent bearish calls from Morgan StanleyMS-- have pulled the average down.
Fundamental Highlights
- Net profit attributable to parent company shareholders / Net profit: 99.47% – Internal diagnostic score: 1.0
- EV/EBIT: 136.78 – Internal diagnostic score: 2.0
- Net cash flow from operating activities per share (YoY): 5.14% – Internal diagnostic score: 1.0
- Cost of sales ratio: 42.61% – Internal diagnostic score: 3.0
- Interest coverage ratio (EBIT / Interest): 11.55% – Internal diagnostic score: 3.0
- Total profit (YoY): 8.43% – Internal diagnostic score: 2.0
- Total assets turnover ratio: 24.18% – Internal diagnostic score: 3.0
Money-Flow Trends
Large institutional investors are currently net buyers of TXN. The block inflow ratio is 55.35%, suggesting that big-money players are accumulating positions. Meanwhile, retail investors are more divided: the overall inflow ratio is 54.40%, with large and extra-large investors showing the most positive sentiment. This contrast suggests a possible long-term confidence despite recent price weakness.
Key Technical Signals
Technically, TXN is in a weak position. The internal technical score is 2.98, and key indicators reinforce a bearish bias.
- WR Oversold: Internal diagnostic score: 2.32 – Neutral to rising, but with only a 45% win rate historically.
- Bearish Engulfing: Internal diagnostic score: 1.0 – Strongly bearish, with a poor historical win rate of just 25%.
- RSI Oversold: Internal diagnostic score: 5.61 – Suggests potential for a bounce, but still bearish in context.
Recent Chart Patterns (Last 5 Days):
- 2025-09-10: WR Oversold, Bearish Engulfing, RSI Oversold
- 2025-09-12: WR Oversold, RSI Oversold
- 2025-09-11: WR Oversold, RSI Oversold
- 2025-09-09: WR Oversold, RSI Oversold
- 2025-09-08: WR Oversold, Bearish Engulfing, RSI Oversold
The consistent appearance of WR Oversold and Bearish Engulfing signals a weak momentum with a high risk of further decline.
Conclusion
Despite robust fundamentals and positive institutional flows, TXN is currently weighed down by poor technical signals and a divergent analyst outlook. The recent price drop (-10.82%) and bearish candlestick patterns suggest caution. Investors should consider waiting for a pull-back or better technical confirmation before committing. For now, monitoring upcoming earnings and trade policy updates could provide key directional clues for the stock.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet